Endomorphins: The Body's Most Selective Natural Painkillers for the Mu-Opioid Receptor
Endomorphins 1 and 2 are the most selective natural mu-opioid receptor ligands, with potent analgesic activity and distinct pharmacological profiles suggesting different clinical applications.
Quick Facts
What This Study Found
Endomorphins 1 and 2 are the most mu-opioid selective endogenous peptides, with potent analgesia and distinct pharmacological profiles suggesting separate roles in pain modulation and unique therapeutic potential.
Key Numbers
How They Did This
Comprehensive review of endomorphin discovery, receptor pharmacology, tissue distribution, analgesic properties, and therapeutic implications.
Why This Research Matters
Current opioid drugs lack selectivity, causing addiction and side effects. Endomorphins' exceptional mu-selectivity provides a template for designing cleaner, more targeted analgesics.
The Bigger Picture
The opioid crisis demands better painkillers. Endomorphins' mu-selectivity template could guide design of analgesics that match the body's own most selective pain-relieving mechanism.
What This Study Doesn't Tell Us
Endomorphins as peptides have limited stability and bioavailability. Some pharmacological characterizations were still preliminary.
Questions This Raises
- ?Can endomorphin-based drugs achieve oral stability?
- ?Would endomorphin-selective agonists be less addictive than morphine?
- ?Why does the body need two different mu-selective endomorphins?
Trust & Context
- Key Stat:
- Most selective natural opioids Endomorphins have the highest mu-opioid receptor selectivity of any known endogenous opioid — nature's most precise painkillers
- Evidence Grade:
- Moderate evidence from a comprehensive review of endomorphin pharmacology establishing their unique position among endogenous opioids.
- Study Age:
- Published in 2002. Endomorphin research has continued, with endomorphin-based drug candidates in various stages of development.
- Original Title:
- Endomorphins and related opioid peptides.
- Published In:
- Vitamins and hormones, 65, 257-79 (2002)
- Authors:
- Okada, Yoshio, Tsuda, Yuko, Bryant, Sharon D, Lazarus, Lawrence H
- Database ID:
- RPEP-00754
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What are endomorphins?
They're the body's own most targeted painkillers — tiny 4-amino acid peptides that activate the mu-opioid receptor (the same one morphine targets) with exceptional precision and fewer off-target effects.
Could they lead to better painkillers?
Yes. Their exceptional selectivity shows it's possible to target the mu-opioid receptor precisely. Drugs modeled on endomorphins might provide pain relief with less addiction potential and fewer side effects than current opioids.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00754APA
Okada, Yoshio; Tsuda, Yuko; Bryant, Sharon D; Lazarus, Lawrence H. (2002). Endomorphins and related opioid peptides.. Vitamins and hormones, 65, 257-79.
MLA
Okada, Yoshio, et al. "Endomorphins and related opioid peptides.." Vitamins and hormones, 2002.
RethinkPeptides
RethinkPeptides Research Database. "Endomorphins and related opioid peptides." RPEP-00754. Retrieved from https://rethinkpeptides.com/research/okada-2002-endomorphins-and-related-opioid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.